MOSCOW - Scores of Russia's business and political elite have been given early access to an experimental vaccine against Covid-19, according to people familiar with the effort, as the country races to be among the first to develop an inoculation.
Gamaleya's press office couldn't be reached immediately for comment. Kremlin spokesman Dmitry Peskov, who recovered from Covid-19 after being hospitalised with the virus in May, said he doesn't know the names of anyone who's received the institute's vaccine. While the new shots are"safe" because they're based on proven vaccines for other diseases, their effectiveness has yet to be determined, according to Sergei Netesov, a former executive at Vector, a state-run virology centre in Novosibirsk, Siberia, that's also working on an inoculation.Russia has reported more than 750,000 cases of Covid-19, the fourth-largest total in the world, and Gamaleya's program is on a faster track than many developers in the West.
The program under which well-connected Russians have been given the chance to volunteer for doses of the experimental vaccine is legal but kept under wraps to avoid a crush of potential participants, according to a researcher familiar with the effort. He said several hundred people have been involved. Bloomberg confirmed dozens who have had the shots but none would allow their names to be published.
One senior executive who's been inoculated said he experienced no side effects. He said the health risks are worth being able to resume normal life, both personal and professional. Other takers reported experiencing fevers and muscle aches after getting the shots.
Singapore Latest News, Singapore Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Source: ChannelNewsAsia - 🏆 6. / 66 Read more »
Source: ChannelNewsAsia - 🏆 6. / 66 Read more »
Source: BusinessTimes - 🏆 15. / 51 Read more »
Source: YahooSG - 🏆 3. / 71 Read more »
Source: TODAYonline - 🏆 1. / 99 Read more »
Source: The Straits Times - 🏆 8. / 63 Read more »